(Image: Getty/Oatawa)

Almac expands neo-antigen peptide manufacturing

By Maggie Lynch

Almac announced it has increased its supply of neo-antigen peptides for individualized cancer treatments with the addition of another stream of GMP manufacturing.

Cambridge Major expands

Cambridge Major expands

Cambridge Major Laboratories expects to complete construction of a
new process R&D and manufacturing facility in the middle of
2004 that will make it one of the largest Good Manufacturing
Practice (GMP) development and small-scale...